ALG1 siRNA (Human)

CAT: 1601-CRJ1043-01Size: 15 nmolDry Ice: NoHazardous: No
CAT#:1601-CRJ1043-01Size:15 nmol
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
SiRNA to inhibit ALG1 expression using RNA interference
Product Name Alternative
HMAT1; HMT1; Chitobiosyldiphosphodolichol beta-mannosyltransferase; Asparagine-linked glycosylation protein 1 homolog; Beta-1.4-mannosyltransferase; GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase; GDP-mannose-dolichol diphosphochitobiose mannosyltransferase; Mannosyltransferase-1; MT-1; hMat-1
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human ALG1 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
ALG1 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
ALG1
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q9BT22
Entrez GeneHuman
56052

Popular Products